Fig. 5From: Visumax femtolasik versus Moria M2 microkeratome in mild to moderate myopia: efficacy, safety, predictability, aberrometric changes and flap thickness predictabilityChanges in CDVA in Visumax group (group I) and Moria M2 MK (group II)Back to article page